Search

everythinglearnresearchcommunity

for

Search:↓

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Experts discussed treatments for skin conditions in children, emphasizing hydration, cautious medication use, and early intervention for infections.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

Using defensins to activate stem cells may improve skin aging signs without causing inflammation.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Special particles from umbilical cord stem cells help heal skin wounds in diabetic mice by preventing certain immune cell death.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Topical treatments led to hair regrowth in a man with linear morphea.

Narrowband-UVB phototherapy successfully treated a rare case of Graham Little-Piccardi-Lassueur syndrome.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

A new hydrogel with stem cells from the human umbilical cord speeds up healing in diabetic wounds.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

VKHD and sarcoidosis may share a common cause.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Chronic bacterial infections of hair follicles can cause ongoing skin inflammation.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.